PECAM1 and neoplasm: Additionally, the number of CD31-positive endothelial cells in the combined treatment groups was significantly decreased compared to that from either the vehicle control group or single-agent groups (Fig. 6a), suggesting a remarkable reduction of tumor neovascularization.